Oman licenses world's first oral drug for Multiple Sclerosis

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

Oman licenses world's first oral drug for Multiple Sclerosis

Postby MSUK » Mon Jul 25, 2011 7:32 am

Image


Oman has licensed the world's first oral medication for Multiple Sclerosis (MS), a move which medical experts say will improve medication tolerability and compliance for many of Oman's 200 MS sufferers.

The Oman Ministry of Health has approved the Novartis-made drug Gilenya (fingolimod) for use in the relapsing remitting form of MS that affects around two-thirds of those diagnosed with the disease, which causes muscle weakness, problems with coordination and impaired concentration.

Making the new oral tablets available will remove the need for patients to undergo regular injections, allowing patients to enjoy a less restricted way of life and improving medication acceptance and compliance for those who cannot tolerate injections, said a leading Oman-based doctor who specialises in MS. Improved medication acceptance and compliance will optimize patient outcomes.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2144
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service